| Product Code: ETC7740412 | Publication Date: Sep 2024 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
In 2024, Japan saw consistent import shipments of insulin drugs and delivery devices from key countries such as Germany, Switzerland, USA, Italy, and Metropolitan France. Despite a slight decline in the growth rate from 2023 to 2024, the market remained fairly competitive with a low Herfindahl-Hirschman Index (HHI) concentration. The overall compound annual growth rate (CAGR) from 2020 to 2024 showed a decrease of -5.32%, indicating a challenging market environment. This data suggests a stable yet slightly declining trend in the importation of insulin products in Japan.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Japan Insulin Drugs & Delivery Devices Market Overview |
3.1 Japan Country Macro Economic Indicators |
3.2 Japan Insulin Drugs & Delivery Devices Market Revenues & Volume, 2021 & 2031F |
3.3 Japan Insulin Drugs & Delivery Devices Market - Industry Life Cycle |
3.4 Japan Insulin Drugs & Delivery Devices Market - Porter's Five Forces |
3.5 Japan Insulin Drugs & Delivery Devices Market Revenues & Volume Share, By Drug, 2021 & 2031F |
3.6 Japan Insulin Drugs & Delivery Devices Market Revenues & Volume Share, By Device, 2021 & 2031F |
4 Japan Insulin Drugs & Delivery Devices Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of diabetes in Japan |
4.2.2 Technological advancements in insulin delivery devices |
4.2.3 Growing awareness about the importance of diabetes management |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for insulin drugs and devices |
4.3.2 High cost associated with insulin medications |
4.3.3 Limited access to healthcare services in certain regions of Japan |
5 Japan Insulin Drugs & Delivery Devices Market Trends |
6 Japan Insulin Drugs & Delivery Devices Market, By Types |
6.1 Japan Insulin Drugs & Delivery Devices Market, By Drug |
6.1.1 Overview and Analysis |
6.1.2 Japan Insulin Drugs & Delivery Devices Market Revenues & Volume, By Drug, 2021- 2031F |
6.1.3 Japan Insulin Drugs & Delivery Devices Market Revenues & Volume, By Basal or Long-acting Insulins, 2021- 2031F |
6.1.4 Japan Insulin Drugs & Delivery Devices Market Revenues & Volume, By Bolus or Fast-acting Insulins, 2021- 2031F |
6.1.5 Japan Insulin Drugs & Delivery Devices Market Revenues & Volume, By Traditional Human Insulins, 2021- 2031F |
6.1.6 Japan Insulin Drugs & Delivery Devices Market Revenues & Volume, By Combination Insulins, 2021- 2031F |
6.1.7 Japan Insulin Drugs & Delivery Devices Market Revenues & Volume, By Biosimilar Insulins, 2021- 2031F |
6.2 Japan Insulin Drugs & Delivery Devices Market, By Device |
6.2.1 Overview and Analysis |
6.2.2 Japan Insulin Drugs & Delivery Devices Market Revenues & Volume, By Insulin Pens, 2021- 2031F |
6.2.3 Japan Insulin Drugs & Delivery Devices Market Revenues & Volume, By Insulin Pumps, 2021- 2031F |
6.2.4 Japan Insulin Drugs & Delivery Devices Market Revenues & Volume, By Insulin Syringes, 2021- 2031F |
6.2.5 Japan Insulin Drugs & Delivery Devices Market Revenues & Volume, By Insulin Jet Injectors, 2021- 2031F |
7 Japan Insulin Drugs & Delivery Devices Market Import-Export Trade Statistics |
7.1 Japan Insulin Drugs & Delivery Devices Market Export to Major Countries |
7.2 Japan Insulin Drugs & Delivery Devices Market Imports from Major Countries |
8 Japan Insulin Drugs & Delivery Devices Market Key Performance Indicators |
8.1 Number of diabetic patients using insulin drugs and delivery devices |
8.2 Adoption rate of new insulin delivery technologies in Japan |
8.3 Average time taken for regulatory approvals for insulin products in the market |
9 Japan Insulin Drugs & Delivery Devices Market - Opportunity Assessment |
9.1 Japan Insulin Drugs & Delivery Devices Market Opportunity Assessment, By Drug, 2021 & 2031F |
9.2 Japan Insulin Drugs & Delivery Devices Market Opportunity Assessment, By Device, 2021 & 2031F |
10 Japan Insulin Drugs & Delivery Devices Market - Competitive Landscape |
10.1 Japan Insulin Drugs & Delivery Devices Market Revenue Share, By Companies, 2024 |
10.2 Japan Insulin Drugs & Delivery Devices Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here